Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
Balchem (NASDAQ: BCPC) will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Balchem (NASDAQ: BCPC) will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Senior management attendees include Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director, Investor Relations).
The company will present and engage with investors at the industry conference, offering updates on strategy and market positioning for health and nutrition ingredients.
Details
News Market Reaction – BCPC
On Feb 24, the day this news came out, BCPC closed 1.64% above the previous close.
Data tracked by StockTitan Argus for the Feb 24 session.
Key Figures
- Conference date
- March 10, 2026
- JP Morgan Consumer Ingredients Forum participation
Historical Context
-
Record 2025 sales, EBITDA and free cash flow with higher EPS and dividend.
-
Announcement of Q4 and full-year 2025 earnings call and webcast details.
-
Participation in CJS virtual conference to discuss strategy with investors.
-
EU anti-dumping duties on Chinese choline chloride supporting EU producers.
-
Annual dividend raised 10.3%, seventeenth consecutive yearly increase.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTVALE, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Contact: Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.